Lage A P, Godfroid E, Fauconnier A, Burette A, Butzler J P, Bollen A, Glupczynski Y
Service de Génétique Appliquée, Université Libre de Bruxelles, Nivelles, Belgium.
J Clin Microbiol. 1995 Oct;33(10):2752-6. doi: 10.1128/jcm.33.10.2752-2756.1995.
A PCR assay for the detection of Helicobacter pylori in gastric biopsy specimens with specific primers for ureC gene amplification (herein referred to as ureC PCR) was compared with other routine invasive methods (culture, the rapid-urease test, and Giemsa staining of histological sections) with samples from a group of 104 consecutive dyspeptic patients. Bacteria were found in 40 (38.5%), 38 (36.5%), 36 (34.6%), and 35 (33.7%) of the patients by ureC PCR, culture, the rapid-urease test, and Giemsa stain, respectively. Sixty-three patients had negative cultures, negative histological examinations, and negative rapid-urease test results, and 61 of these patients were also negative by ureC PCR. ureC PCR detected H. pylori in two culture-negative patients. In parallel, a PCR-based assay to detect the H. pylori cytotoxin-associated antigen (cagA) gene, a putative virulence gene, was also developed. To assess the likelihood of detection of H. pylori genes directly from gastric biopsy samples and from the corresponding H. pylori isolates, specimens from 31 patients were subjected to PCR with ureC- and cagA-targeting primers. All 31 biopsy specimens and the corresponding H. pylori isolates were positive in the ureC PCR. H. pylori strains that were cagA positive also gave positive cagA PCR fragments with biopsy specimens from the same patients. All ureC PCR-positive patients were examined; biopsy specimens from 10 of 11 (91.7%) duodenal ulcer patients harbored H. pylori cagA-positive strains, whereas 19 of26 (73%) of those from patients with chronic gastritis only were found to be cagA positive. These findings indicate first that ureC PCR is at least as sensitive as culture for diagnosing H. pylori infection and second that the presence of the H. pylori cagA gene can also be detected directly in biopsy specimens by PCR amplification.
采用针对ureC基因扩增的特异性引物对胃活检标本进行幽门螺杆菌检测的聚合酶链反应(PCR)分析(以下简称ureC PCR),与其他常规侵入性方法(培养、快速尿素酶试验以及组织切片的吉姆萨染色),对一组连续的104例消化不良患者的样本进行了比较。通过ureC PCR、培养、快速尿素酶试验和吉姆萨染色分别在40例(38.5%)、38例(36.5%)、36例(34.6%)和35例(33.7%)患者中发现了细菌。63例患者培养、组织学检查和快速尿素酶试验结果均为阴性,其中61例患者ureC PCR结果也为阴性。ureC PCR在两名培养阴性的患者中检测到了幽门螺杆菌。同时,还开发了一种基于PCR的检测幽门螺杆菌细胞毒素相关抗原(cagA)基因(一种假定的毒力基因)的分析方法。为了评估直接从胃活检样本和相应的幽门螺杆菌分离株中检测幽门螺杆菌基因的可能性,对31例患者的标本用靶向ureC和cagA的引物进行了PCR。所有31份活检标本和相应的幽门螺杆菌分离株ureC PCR均为阳性。cagA阳性的幽门螺杆菌菌株与来自同一患者的活检标本进行cagA PCR时也产生了阳性片段。对所有ureC PCR阳性患者进行了检查;11例十二指肠溃疡患者中有10例(91.7%)的活检标本中含有幽门螺杆菌cagA阳性菌株,而仅患有慢性胃炎的患者中,26例中有19例(73%)的活检标本被发现cagA阳性。这些发现首先表明ureC PCR在诊断幽门螺杆菌感染方面至少与培养一样敏感,其次表明通过PCR扩增也可以直接在活检标本中检测到幽门螺杆菌cagA基因的存在。